An A1C-to-glucose chart converts your A1C percentage into estimated average glucose, or eAG, in mg/dL or mmol/L. For example, an A1C of 7% equals an estimated average glucose of about 154 mg/dL. A1C reflects longer-term glucose exposure, while finger-stick or CGM readings show specific moments in time.1
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →| A1C | Estimated average glucose (mg/dL) | Estimated average glucose (mmol/L) | Common clinical meaning |
|---|---|---|---|
| 5.0% | 97 | 5.4 | Often in the normal range |
| 5.5% | 111 | 6.2 | Often in the normal range |
| 5.7% | 117 | 6.5 | Common lower cut point for prediabetes |
| 6.0% | 126 | 7.0 | Prediabetes range in many guidelines |
| 6.5% | 140 | 7.8 | Common diagnostic cut point for diabetes |
| 7.0% | 154 | 8.6 | Common treatment goal for many nonpregnant adults with diabetes, individualized by clinician |
| 8.0% | 183 | 10.2 | Above goal for many adults, but targets vary |
| 9.0% | 212 | 11.8 | Often prompts a clinician review of the care plan |
| 10.0% | 240 | 13.3 | Often prompts a clinician review of medications, safety, and symptoms |
This chart uses the ADAG relationship between hemoglobin A1C, also called HbA1c or glycated hemoglobin, and estimated average glucose. The American Diabetes Association describes eAG as a way to report A1C in the same units people see on a glucose meter: mg/dL in the U.S. or mmol/L in many other countries.1
What does an A1C-to-glucose chart show?
A1C-to-glucose charts show the average blood glucose that matches an A1C percentage. The key number many people look up is 7% A1C = about 154 mg/dL, but it is still an estimate, not a direct meter reading.2
Quick facts: A1C, eAG, mg/dL, and mmol/L
- A1C is a blood test that reflects how much glucose has attached to hemoglobin in red blood cells over time.2
- Estimated average glucose, or eAG, translates A1C into glucose units used by meters and CGMs.1
- mg/dL means milligrams per deciliter. mmol/L means millimoles per liter.
- For glucose, mmol/L = mg/dL ÷ 18. For example, 154 mg/dL is about 8.6 mmol/L.
The simple difference between A1C and daily glucose readings
A finger-stick meter or continuous glucose monitoring system, called a CGM, shows glucose at a moment or across the day. A1C is different. It reflects longer-term glycemic exposure and does not require fasting, which is one reason clinicians use it for screening and follow-up.3
Why A1C is reported as a percentage
A1C is reported as the percent of hemoglobin that has glucose attached. That percent can feel abstract, so eAG helps connect the lab result to everyday glucose numbers.
How do you convert A1C to estimated average glucose?
Estimated average glucose is calculated from A1C with a formula from the ADAG study. The most common formula is eAG mg/dL = 28.7 × A1C − 46.7.2
A1C to glucose conversion formula
Use this as a reference formula, not a diagnosis: eAG in mg/dL = 28.7 × A1C − 46.7. To convert that result to mmol/L, divide by 18. For example, an A1C of 7% gives 28.7 × 7 − 46.7 = 154 mg/dL, which is about 8.6 mmol/L.2
Example conversions: A1C 5.7%, 6.5%, 7%, 8%, and 9%
| A1C | eAG in mg/dL | eAG in mmol/L | How to think about it |
|---|---|---|---|
| 5.7% | 117 | 6.5 | Common starting point for the prediabetes range |
| 6.5% | 140 | 7.8 | Common diabetes diagnostic cut point |
| 7.0% | 154 | 8.6 | Often used as a treatment target for many adults, but goals are personal |
| 8.0% | 183 | 10.2 | Above goal for many adults |
| 9.0% | 212 | 11.8 | Usually needs clinician review |
What do A1C ranges mean for normal blood sugar, prediabetes, and diabetes?
A1C ranges are screening and care-planning tools, not a full diagnosis by themselves. A commonly used cut point is 6.5% for diabetes, based partly on evidence linking A1C levels with retinopathy risk.3
| A1C range | Common category | What to do next |
|---|---|---|
| Below 5.7% | Often considered normal | Ask your clinician how it fits with your fasting glucose, symptoms, and risk factors. |
| 5.7% to 6.4% | Prediabetes range | Discuss insulin resistance, food patterns, activity, sleep, weight, and follow-up testing. |
| 6.5% or higher | Diabetes range when confirmed by a clinician | Your clinician may repeat testing or compare with fasting plasma glucose, OGTT, symptoms, and other labs. |
Higher A1C levels are linked with higher future diabetes risk in prospective studies, but one lab result should not be read alone.3 If your result is near a cut point, it can help to read our guide to the A1C blood sugar test and bring questions to your clinician.
Why might your meter, CGM, and A1C not match exactly?
A1C, meters, and CGMs measure related but different things. A1C estimates longer-term exposure, while a CGM can show minute-to-minute glucose patterns, including meal spikes and overnight lows.4
A1C is a long-term average, not a real-time reading
Two people can have the same A1C but different daily patterns. One person may have steady glucose. Another may swing high after meals and low overnight. A1C can hide that pattern because it is an average.
Post-meal glucose spikes can be missed by fasting tests
Fasting plasma glucose checks one point after not eating. Postprandial glucose means glucose after a meal. In people without diabetes, post-meal glucose often peaks around 30 to 45 minutes and trends back toward pre-meal levels within about 2 to 3 hours, but patterns can differ in diabetes and pregnancy.5
When A1C may be less reliable
A1C can be harder to interpret in some situations, including anemia, pregnancy, kidney disease, recent blood loss or transfusion, and hemoglobin variants. If your A1C does not match your home readings, ask whether fasting glucose, after-meal checks, CGM data, or an oral glucose tolerance test would give a clearer picture.4
How do fasting glucose and after-meal glucose fit with A1C?
Fasting glucose and after-meal glucose help explain the pattern behind an A1C. A1C gives the longer view, while fasting and postprandial readings show what is happening at specific times.5
Fasting glucose: a snapshot after not eating
Fasting glucose is usually checked after not eating overnight. It can be affected by sleep, stress, illness, medications, hormones, and what happened the day before. For more reference ranges, see our normal blood sugar levels chart.
Postprandial glucose and OGTT
Postprandial glucose is measured after a meal. An oral glucose tolerance test, or OGTT, measures the glucose response after a fixed glucose drink. Reviews of glycemic impact measures describe OGTT and post-meal glucose as tools used in diabetes and pregnancy care, though exact targets depend on the clinical situation.5
How food changes glycemic impact
A meal’s glycemic impact depends on the amount and type of available carbohydrate, fiber, food form, fat, protein, and the person’s physiology. Glycemic index ranks carbohydrate-containing foods by glucose effect, while glycemic load also accounts for the amount of carbohydrate in a serving.5
What can help improve A1C when it is above your target?
Improving A1C usually takes a plan, not one food rule. The strongest approach often combines food pattern changes, activity, sleep, weight care when appropriate, and medication adherence, with a goal set by your clinician over about 3 months.4
Food patterns with the strongest practical evidence
For many people, practical steps include choosing higher-fiber carbohydrates, spreading carbohydrates across meals, pairing carbohydrate with protein or healthy fat, and limiting sugar-sweetened drinks. If you have prediabetes, our diet chart for prediabetes and Mediterranean diet for prediabetes guides can help you prepare questions for a clinician or dietitian.
Weight loss, activity, sleep, and medication adherence
In the Diabetes Prevention Program, intensive lifestyle changes lowered diabetes incidence by 58% and metformin lowered it by 31% compared with placebo over about 2.8 years in high-risk adults; individual results vary.6 If insulin resistance is part of your picture, read our guide on how to reverse insulin resistance for food, activity, testing, and medication questions.
Why there is no single “number one enemy” food
There is no one worst food for every person with diabetes. Portion size, fiber, meal mix, medication timing, activity, sleep, and glucose pattern all matter. A sugary drink may raise glucose quickly for many people, but the best plan is still personal.
When low blood sugar needs fast-acting carbohydrate
Hypoglycemia means blood sugar is too low. It can be dangerous, especially for people using insulin or certain diabetes pills. Many diabetes care plans use fast-acting carbohydrate for low blood sugar rather than a mixed meal, but your own threshold and treatment plan should come from your diabetes clinician.4
3-min quiz
Considering weight care alongside A1C goals?
Chia offers clinician-reviewed weight care for eligible adults, including compounded semaglutide injection and compounded tirzepatide tablets or injections. A prescription requires an online medical evaluation by a licensed US provider and is not guaranteed. Compounded drugs are not FDA-approved.
Where can weight-related treatment fit if A1C and insulin resistance are concerns?
Weight-related treatment can be part of care for some people with prediabetes, insulin resistance, or type 2 diabetes risk. A sustained weight-loss plan can improve insulin resistance for some people, but diabetes medication decisions should stay with the clinician managing your diabetes.6
How GLP-1 and GIP/GLP-1 medications relate to appetite, weight, and glucose biology
Semaglutide is a GLP-1 receptor agonist. Wegovy and Ozempic are brand-name semaglutide products with different labeled uses; compounded semaglutide via a 503A pharmacy is a compounded formulation and is not FDA-approved. GLP-1 medicines can slow gastric emptying, affect appetite pathways, and increase glucose-dependent insulin secretion; nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis warnings, and contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 require clinician review.7
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Mounjaro and Zepbound are brand-name tirzepatide products with different labeled uses; compounded tirzepatide via a 503A pharmacy is a compounded formulation and is not FDA-approved. Tirzepatide can affect appetite and glucose biology, and its label includes gastrointestinal side effects, gallbladder warnings, pancreatitis warnings, and a boxed warning about thyroid C-cell tumors; use with insulin or insulin secretagogues may raise hypoglycemia risk and needs clinician oversight.8
If you use insulin, sulfonylureas, or other glucose-lowering medicines, do not adjust them on your own. GLP-1 or GIP/GLP-1 medication decisions should be coordinated with the clinician who manages your diabetes care.
Weight care at Chia when A1C, prediabetes, or insulin resistance overlap with weight goals
Chia weight care is for eligible adults seeking clinician-reviewed weight-loss treatment, not emergency care or diabetes management. Our process is 100% online: a short health questionnaire, licensed US provider review, provider-guided dosing when appropriate, and home delivery from state-licensed 503A compounding pharmacies.
At Chia, semaglutide injection plans currently start at $249/mo, with microdosing plans available when clinically appropriate. We also offer tirzepatide tablets or injections: tablets currently start at $249/mo and injections currently start at $299/mo, with microdosing plans available when appropriate.
| Chia option | Forms Chia offers | Current starting price | Good fit to discuss if |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | You want a provider-guided GLP-1 weight-care option and are comfortable with injections. |
| Tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | You want to discuss a dual GIP/GLP-1 option, including a non-injection form if appropriate. |
Chia does not diagnose or manage diabetes emergencies through an article, and Chia weight care is not a replacement for your diabetes clinician. If you have vomiting with high glucose, severe hypoglycemia symptoms, chest pain, trouble breathing, confusion, fainting, or symptoms your clinician has told you are urgent, seek urgent medical care.
What should you ask your clinician about your A1C result?
Your A1C result is most useful when it leads to the right next question. Bring the number, the date, your medications, and any meter or CGM data from the last 2 to 4 weeks if you have it.
- What is my personal A1C goal, and why?
- Should we compare my A1C with fasting glucose, after-meal glucose, or CGM data?
- Could anemia, pregnancy, kidney disease, a hemoglobin variant, or another factor make my A1C less reliable?
- Do I need repeat testing, an oral glucose tolerance test, or medication review?
- Would nutrition support, activity changes, sleep work, or weight-care options fit my situation?
- If I take insulin or other glucose-lowering medicine, what is my low blood sugar plan?
3-min quiz
Start a clinician-reviewed weight-care visit
If weight goals overlap with A1C, prediabetes, or insulin resistance concerns, Chia can help eligible adults explore compounded semaglutide injection or compounded tirzepatide tablets or injections. A licensed US provider reviews your intake and prescribes only when clinically appropriate; a prescription is not guaranteed. Compounded drugs are not FDA-approved.
FAQ
Use the formula eAG in mg/dL = 28.7 × A1C − 46.7. For example, an A1C of 7% is about 154 mg/dL. To convert mg/dL to mmol/L, divide by 18.
Many guidelines use 6.5% or higher as a diabetes-range A1C when confirmed by a clinician. But “no longer diabetic” is not based on one number alone. Your clinician will consider your history, medications, repeat labs, and whether diabetes is in remission or still being treated.
Not exactly. A1C is a lab percentage that reflects longer-term glucose exposure. Estimated average glucose, or eAG, converts that percentage into mg/dL or mmol/L so it is easier to compare with meter or CGM readings.
Yes. A1C is an average, so it can miss short glucose spikes after meals. If symptoms or CGM data suggest spikes, ask your clinician whether after-meal checks or another test would help.
There is no single “number one enemy” food for every person. Sugary drinks can raise glucose quickly for many people, but the full meal pattern, portion size, fiber, medication plan, activity, and personal glucose response matter.
It may not act fast enough for urgent low blood sugar because peanut butter contains fat and protein, which can slow digestion. People at risk for hypoglycemia should follow the low blood sugar plan given by their diabetes clinician.
Weight loss can improve insulin resistance and A1C for some people, especially when combined with food, activity, sleep, and medication support. Individual results vary, and diabetes medication changes should be made with the clinician managing your diabetes.
Chia offers clinician-reviewed weight care for eligible adults, including compounded semaglutide injection and compounded tirzepatide tablets or injections. Chia does not replace your diabetes clinician, diagnose diabetes through an article, or manage diabetes emergencies. Compounded drugs are not FDA-approved.
References
- 1.American Diabetes Association. eAG/A1C Conversion Calculator. American Diabetes Association Professional Practice Committee, 2026.
- 2.Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care, 2008.
- 3.Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KM, Imperatore G, Williams DE, Albright AL. A1C level and future risk of diabetes: a systematic review. Diabetes Care, 2010.
- 4.American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026: Glycemic Goals and Hypoglycemia. Diabetes Care, 2026.
- 5.Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Global evaluation of the use of glycaemic impact measures in food or nutrient labelling and claims. Nutrition Research Reviews, 2021.
- 6.Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 2002.
- 7.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA, 2024.
- 8.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA, 2023.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
